TD Cowen Says Novartis (NVS) Has Strong Growth Path Through 2029
Novartis AG (NYSE:NVS) ranks among the best slow growth stocks to invest in. Following meetings with Novartis AG (NYSE:NVS)’s head of U.S.
Novartis A G (NVS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 7,239,366 | $928,376,319 | +2% | 0.34% |
| 2. | GQG Partners Rajiv Jain | 2,262,867 | $290,194,467 | +3519% | 0.45% |
| 3. | Renaissance Technologies Jim Simons | 1,877,831 | $240,813,047 | -19% | 0.32% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,168,757 | $149,881,397 | -19% | 0.15% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 863,633 | $110,752,296 | -2% | 0.14% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,585,145 | $1,357,438,995 | 0.73% | |
| 2. | 9,341,854 | $1,197,999,355 | 0.92% | |
| 3. | 8,840,686 | $1,133,468,010 | 0.24% | |
| 4. | 7,728,873 | $991,151,030 | 0.06% | |
| 5. | 5,664,911 | $726,468,235 | 0.86% |
News See All
12 Best Slow Growth Stocks to Invest In
On the night of November 27, during a week cut by Thanksgiving, stock futures saw minimal movement, with the Nasdaq Composite poised to end a seven-month winning run.
Morgan Stanley Upgrades Novartis (NVS) to Overweight, Raises Price Target to CHF 110
On October 31, Morgan Stanley upgraded Novartis AG (NYSE:NVS) to Overweight from Equal Weight, raising its price target to CHF 110 from CHF 108, as reported by The Fly.
12 Best European Dividend Stocks to Buy Now
Dividend investing has been gaining traction among investors not only in the US but across global markets.
Novartis AG (NYSE:NVS) Q3 2025 Earnings Call Transcript
Operator: Good morning and good afternoon, and welcome to the Novartis Q3 2025 Results Release Conference Call and Live Webcast. [Operator Instructions] The conference is being recorded.
15 Stocks Were Recently Put Under the Microscope By Jim Cramer
“Bulls waste a huge amount of time shadowboxing the bears. Yeah, the bulls are always on the defensive, even when they have the history, the data, and the numbers on their side.
Novartis Receives FDA Approval for Rhapsido (remibrutinib) for Chronic Spontaneous Urticaria
Novartis (NYSE:NVS) is one of the best growth stocks to buy now. On September 30, Novartis announced the US FDA approval of its drug, Rhapsido (remibrutinib).
12 Best Growth Stocks to Buy Now
On October 1, Keith Lerner, Chief Investment Officer at Truist Wealth, appeared on CNBC and stated that the shutdown fears are muted, and investors are not overly concerned right now.
11 Most Undervalued Growth Stocks to Buy According to Hedge Funds
On September 25, Stephen Parker, JPMorgan Private Bank's co-head of global investment strategy, joined CNBC for an interview to discuss the driving factors of the market.
Novartis AG (NVS) Strengthens Cardiovascular Unit with Tourmaline Bio Acquisition
Novartis AG (NYSE:NVS) is one of the best defensive stocks to buy, according to Steve Cohen.
Hedge Fund Resource Center Billionaire Hedge Funds
